Interplay between C1-inhibitor and group IIA secreted phospholipase A

Humans Angioedemas, Hereditary Interleukin-6 Leukocytes, Mononuclear Molecular Docking Simulation Tumor Necrosis Factor-alpha Complement C1 Inhibitor Protein / chemistry Group II Phospholipases A2 / chemistry
Angioedema Blood mononuclear cells C1-INH Chemokines Cytokines Phospholipase A2

Journal

Immunologic research
ISSN: 1559-0755
Titre abrégé: Immunol Res
Pays: United States
ID NLM: 8611087

Informations de publication

Date de publication:
02 2023
Historique:
received: 22 07 2022
accepted: 14 10 2022
pubmed: 18 11 2022
medline: 20 1 2023
entrez: 17 11 2022
Statut: ppublish

Résumé

High levels of human group IIA secreted phospholipase A

Identifiants

DOI: 10.1007/s12026-022-09331-7 PMID: 36385678 PMC: PMC9845149
pubmed: 36385678
doi: 10.1007/s12026-022-09331-7
pii: 10.1007/s12026-022-09331-7
pmc: PMC9845149
doi:

Substances chimiques

Interleukin-6 0
Tumor Necrosis Factor-alpha 0
Complement C1 Inhibitor Protein 0
SERPING1 protein, human 0
Group II Phospholipases A2 EC 3.1.1.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-82

Informations de copyright

© 2022. The Author(s).

Références

Curr Protein Pept Sci. 2018;19(10):948-957
pubmed: 28847290
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Molecules. 2021 Nov 30;26(23):
pubmed: 34885848
Biochimie. 2014 Dec;107 Pt A:114-23
pubmed: 25286228
Br J Cancer. 2008 Feb 12;98(3):587-95
pubmed: 18212756
Chem Rev. 2011 Oct 12;111(10):6130-85
pubmed: 21910409
Biochimie. 2010 Jun;92(6):561-82
pubmed: 20347923
Annu Rev Biochem. 2008;77:495-520
pubmed: 18405237
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2395-9
pubmed: 2320562
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
Blood. 2003 Oct 15;102(8):2901-9
pubmed: 12829607
Nucleic Acids Res. 2006 Aug 07;34(13):3698-707
pubmed: 16893954
Proc Natl Acad Sci U S A. 1986 May;83(10):3161-5
pubmed: 3458172
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):789-802
pubmed: 30905346
J Lipid Res. 2015 Jul;56(7):1248-61
pubmed: 25805806
Biochimie. 2013 Jan;95(1):43-50
pubmed: 23022039
J Clin Invest. 1984 Jun;73(6):1542-9
pubmed: 6725552
Biochim Biophys Acta. 1984 Aug 28;789(1):37-43
pubmed: 6432051
J Biol Chem. 2015 Jan 2;290(1):259-71
pubmed: 25398877
Inflammopharmacology. 2021 Aug;29(4):1201-1210
pubmed: 34241784
J Immunol. 2015 Oct 15;195(8):3596-604
pubmed: 26371246
Blood. 1995 Mar 15;85(6):1517-26
pubmed: 7534133
FASEB J. 2003 Jun;17(9):1068-80
pubmed: 12773489
Front Cell Dev Biol. 2021 Jun 10;9:673502
pubmed: 34179001
Biochim Biophys Acta. 2005 Apr 15;1733(2-3):210-23
pubmed: 15863368
Front Immunol. 2017 Apr 19;8:443
pubmed: 28458672
PLoS One. 2011 Mar 25;6(3):e17695
pubmed: 21464987
Blood. 2014 Oct 2;124(14):2173-83
pubmed: 25082876
Pathol Oncol Res. 2013 Oct;19(4):839-46
pubmed: 23722320
Mol Med. 1997 Jun;3(6):385-96
pubmed: 9234243
J Biol Chem. 2007 Jul 20;282(29):21100-9
pubmed: 17488724
Biochemistry. 2012 Oct 30;51(43):8617-26
pubmed: 23020658
J Clin Invest. 1982 Feb;69(2):462-8
pubmed: 6173399
J Mol Biol. 2016 Feb 22;428(4):720-725
pubmed: 26410586
Proteins. 2007 Feb 15;66(3):630-45
pubmed: 17152079
Allergy. 2018 Aug;73(8):1575-1596
pubmed: 29318628
J Immunol Res. 2019 Jul 01;2019:5836476
pubmed: 31355297
J Immunol. 2015 Apr 1;194(7):3327-39
pubmed: 25725101
J Immunol. 2010 May 1;184(9):5232-41
pubmed: 20357262
Cytokine. 2021 Feb;138:155378
pubmed: 33248911
Adv Exp Med Biol. 2013;961:317-26
pubmed: 23224891
Cell Metab. 2022 Apr 5;34(4):615-633.e8
pubmed: 35294862
Proteins. 2005 Oct 1;61(1):21-35
pubmed: 16080151
Scand J Immunol. 2005 Oct;62(4):413-9
pubmed: 16253130
Eur J Biochem. 2000 Aug;267(16):4960-9
pubmed: 10931177
J Immunol. 2008 Jan 15;180(2):1158-68
pubmed: 18178856
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
Biomolecules. 2020 Jun 10;10(6):
pubmed: 32532115
Nat Struct Biol. 1995 Jun;2(6):458-65
pubmed: 7664108
Molecules. 2020 Sep 28;25(19):
pubmed: 32998383
Biochemistry. 2007 Feb 13;46(6):1647-62
pubmed: 17279628
J Biol Chem. 1999 Oct 15;274(42):29927-36
pubmed: 10514475
Front Immunol. 2018 Jul 23;9:1721
pubmed: 30083168
Circulation. 2010 Nov 23;122(21):2183-200
pubmed: 21098459
J Biol Chem. 2011 Oct 21;286(42):36509-21
pubmed: 21878635
Methods Enzymol. 2017;583:35-69
pubmed: 28063498
Biochemistry. 2012 Mar 13;51(10):2136-45
pubmed: 22332920

Auteurs

Anne Lise Ferrara (AL)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
CNR Institute of Experimental Endocrinology and Oncology "G. Salvatore", Naples, Italy.

Maria Bova (M)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
Department of Internal Medicine, Cardarelli Hospital, Naples, Italy.

Angelica Petraroli (A)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Daniela Marasco (D)

Department of Pharmacy, University of Naples Federico II, Naples, Italy.

Christine Payré (C)

Institut de Pharmacologie Moléculaire Et Cellulaire, CNRS, Université Côte d'Azur, Valbonne Sophia Antipolis, Nice, France.

Sara Fortuna (S)

Istituto Italiano Di Tecnologia (IIT), Via E. Melen, 83, 16152, Genoa, Italy.

Francesco Palestra (F)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Renato Ciardi (R)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Gianni Marone (G)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.
CNR Institute of Experimental Endocrinology and Oncology "G. Salvatore", Naples, Italy.

Giuseppe Spadaro (G)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.

Gérard Lambeau (G)

Institut de Pharmacologie Moléculaire Et Cellulaire, CNRS, Université Côte d'Azur, Valbonne Sophia Antipolis, Nice, France.

Stefania Loffredo (S)

Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), WAO Center of Excellence, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy. stefanialoffredo@hotmail.com.
CNR Institute of Experimental Endocrinology and Oncology "G. Salvatore", Naples, Italy. stefanialoffredo@hotmail.com.
ORCID: 0000-0002-5871-1898

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Maladies d'immunodéficience primaire › Déficits héréditaires en complément › Angio-oedèmes héréditaires › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-6 › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Simulation numérique › Simulation de docking moléculaire › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de nécrose tumorale › Facteur de nécrose tumorale alpha › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines inhibitrices de la fraction C1 du complément › C1 Inhibiteur › Interplay between C1-inhibitor and group IIA...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Esterases › Carboxylic ester hydrolases › Phospholipases A › Phospholipases A2 › Secretory Phospholipases A2 › Group II Phospholipases A2 › Interplay between C1-inhibitor and group IIA...